clenbuterol has been researched along with Brain Injuries in 1 studies
Clenbuterol: A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma.
clenbuterol : A substituted aniline that is 2,6-dichloroaniline in which the hydrogen at position 4 has been replaced by a 2-(tert-butylamino)-1-hydroxyethyl group.
Brain Injuries: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with clenbuterol attenuated all IL-1β-induced changes in the striatum including MBS-2 immunoreactivity and TUNEL + staining." | 1.48 | The β ( Boyle, N; Connor, T; Griffin, ÉW; Harkin, A; Harper, P; O'Neill, E; Ryan, KJ; Yssel, JD, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Griffin, ÉW | 1 |
| Yssel, JD | 1 |
| O'Neill, E | 1 |
| Ryan, KJ | 1 |
| Boyle, N | 1 |
| Harper, P | 1 |
| Harkin, A | 1 |
| Connor, T | 1 |
1 other study available for clenbuterol and Brain Injuries
| Article | Year |
|---|---|
The β
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Brain Injuries; Clenbuterol; Inflammation; Interleukin | 2018 |